(Q44057993)

29 November 2017

A critical role for a tyrosine residue in the cannabinoid receptors for ligand recognition (English)

1 reference

29 November 2017

0 references

0 references

0 references

10

1 reference

29 November 2017

Sean D McAllister

1

1 reference

29 November 2017

Qing Tao

2

1 reference

29 November 2017

Judy Barnett-Norris

3

1 reference

29 November 2017

Kurt Buehner

4

1 reference

29 November 2017

Dow P Hurst

5

1 reference

29 November 2017

Frank Guarnieri

6

1 reference

29 November 2017

Patricia H Reggio

7

1 reference

29 November 2017

Katharine W Nowell Harmon

8

1 reference

29 November 2017

Guy A Cabral

9

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

29 November 2017

Biochemical Pharmacology

1 reference

29 November 2017

63

1 reference

29 November 2017

2121-2136

1 reference

29 November 2017

12

1 reference

Molecular cloning of a human cannabinoid receptor which is also expressed in testis

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

Molecular characterization of a peripheral receptor for cannabinoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

Pharmacology of cannabinoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

Pharmacology of cannabinoid CB1 and CB2 receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

A refined model of the thyrotropin-releasing hormone (TRH) receptor binding pocket. Novel mixed mode Monte Carlo/stochastic dynamics simulations of the complex between TRH and TRH receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

Crystal structure of rhodopsin: A G protein-coupled receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

Construction of a 3D model of the cannabinoid CB1 receptor: determination of helix ends and helix orientation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

Analysis and refinement of criteria for predicting the structure and relative orientations of transmembranal helical domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

A proposed structure for transmembrane segment 7 of G protein-coupled receptors incorporating an asn-Pro/Asp-Pro motif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

Functional Microdomains in G-protein-coupled Receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

Agonists induce conformational changes in transmembrane domains III and VI of the beta2 adrenoceptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

Analysis of the relationship between side-chain conformation and secondary structure in globular proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

Aromatic-aromatic interaction: a mechanism of protein structure stabilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

A simple direct assay for cyclic AMP in plasma and other biological samples using an improved competitive protein binding technique.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

Expression of a cannabinoid receptor in baculovirus-infected insect cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

Residues in the fifth membrane-spanning segment of the dopamine D2 receptor exposed in the binding-site crevice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

Complex salt bridges in proteins: statistical analysis of structure and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

Pi-pi interactions: the geometry and energetics of phenylalanine-phenylalanine interactions in proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB(2) receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

Constitutive activation of the beta2 adrenergic receptor alters the orientation of its sixth membrane-spanning segment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

Determination of the amino acid residue involved in [3H]beta-funaltrexamine covalent binding in the cloned rat mu-opioid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

A hydrophobic cluster between transmembrane helices 5 and 6 constrains the thyrotropin-releasing hormone receptor in an inactive conformation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

A cluster of aromatic residues in the sixth membrane-spanning segment of the dopamine D2 receptor is accessible in the binding-site crevice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

Electrostatic and aromatic microdomains within the binding-site crevice of the D2 receptor: contributions of the second membrane-spanning segment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

Dopamine D4/D2 receptor selectivity is determined by A divergent aromatic microdomain contained within the second, third, and seventh membrane-spanning segments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

Relationships between apparent binding energies measured in site-directed mutagenesis experiments and energetics of binding and catalysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

Ligand binding and modulation of cyclic AMP levels depend on the chemical nature of residue 192 of the human cannabinoid receptor 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901031-6

10.1016/S0006-2952(02)01031-6

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference